Aridis Pharmaceuticals, Inc. Annual Operating Income (Loss) in USD from 2017 to 2022

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Aridis Pharmaceuticals, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2017 to 2022.
  • Aridis Pharmaceuticals, Inc. Operating Income (Loss) for the quarter ending September 30, 2023 was -$869K, a 88.3% increase year-over-year.
  • Aridis Pharmaceuticals, Inc. Operating Income (Loss) for the twelve months ending September 30, 2023 was -$883K, a 97.2% increase year-over-year.
  • Aridis Pharmaceuticals, Inc. annual Operating Income (Loss) for 2022 was -$30M, a 29.8% increase from 2021.
  • Aridis Pharmaceuticals, Inc. annual Operating Income (Loss) for 2021 was -$42.7M, a 90.7% decline from 2020.
  • Aridis Pharmaceuticals, Inc. annual Operating Income (Loss) for 2020 was -$22.4M, a 23% increase from 2019.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 -$30M +$12.7M +29.8% Jan 1, 2022 Dec 31, 2022 10-K 2023-05-22
2021 -$42.7M -$20.3M -90.7% Jan 1, 2021 Dec 31, 2021 10-K 2023-05-22
2020 -$22.4M +$6.69M +23% Jan 1, 2020 Dec 31, 2020 10-K 2022-04-13
2019 -$29.1M -$4.97M -20.6% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-30
2018 -$24.1M -$4.38M -22.2% Jan 1, 2018 Dec 31, 2018 10-K 2020-04-08
2017 -$19.7M Jan 1, 2017 Dec 31, 2017 10-K 2019-03-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.